Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT01555541 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large Cell Lymphoma Relapsed/Refractory

Interventions

DRUG: Ofatumumab
DRUG: Etoposide
DRUG: Cytarabine

Sponsor

C. Babis Andreadis

Collaborators

[object Object]
[object Object]